Doctor profile · Federal record
Dr. Sage Dow, CNP
Family Nurse Practitioner (CMS: Nurse Practitioner) · Springfield, MA
- NPI 1871009886
- MIPS 75.0 / 100 · 2023
- 17 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3300 Main St
Springfield, MA 011071112
(413) 794-7552 - Mailing address
-
125 Liberty St, Ste 205
Springfield, MA 011031109
Credentials & registration
- NPI registered
- December 2017 — 9 yrs on file
- Profile last updated
- October 23, 2018
- Year of graduation
- 2009 — 17 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State license (1)
- Massachusetts #RN2268672
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1871009886. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
6,003
Distinct HCPCS
10
Medicare allowed
$271,349
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 3,097 | 337 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,093 | 606 | $78 | |
17000 |
Destruction of precancer skin growth, 1 growth | 630 | 387 | $59 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 286 | 286 | $97 | |
17110 |
Destruction of skin growth, 1-14 growths | 258 | 187 | $101 | |
11102 |
Biopsy of related skin growth, first growth | 191 | 166 | $91 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 106 | 54 | $49 | |
11103 |
Biopsy of related skin growth, each additional growth | 65 | 55 | $45 | |
96372 |
Injection of drug or substance under skin or into muscle | 64 | 11 | $12 | |
J7308 |
Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 60 | 34 | $385 |
In context: peer comparison
Among 42 peers in this city , average services per provider: 98. This provider delivers 61× the peer median.Open Payments
Industry payments received
All-time total
$2,269
Transactions
99
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| GENZYME CORPORATION | 8 | $304.29 | |
| PFIZER INC. | 13 | $274.66 | |
| Novartis Pharmaceuticals Corporation | 18 | $259.82 | |
| ABBVIE INC. | 16 | $239.27 | |
| Regeneron Healthcare Solutions, Inc. | 8 | $198.66 | |
| Lilly USA, LLC | 7 | $191.48 | |
| Amgen Inc. | 6 | $177.14 | |
| Janssen Biotech, Inc. | 5 | $163.19 | |
| LEO Pharma Inc. | 4 | $93.25 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $77.00 | |
| Incyte Corporation | 2 | $58.54 | |
| Dermavant Sciences, Inc. | 2 | $48.24 | |
| Arcutis Biotherapeutics, Inc. | 3 | $46.96 | |
| UCB, Inc. | 2 | $41.68 | |
| Fresenius Kabi USA, LLC | 2 | $34.44 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
68
Patients
18
Total drug cost
$58,556
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 28 | 18 | $386 |
| Dupixent Pen (Dupilumab) | Brand | 14 | 0 | $56,830 |
| Betamethasone Dipropionate | Generic | 13 | 0 | $1,058 |
| Ketoconazole | Generic | 13 | 0 | $282 |
Frequently asked questions
What is Dr. Sage Dow's medical specialty?
Dr. Sage Dow practices Family Nurse Practitioner in Springfield, MA.
Where does Dr. Sage Dow practice?
Dr. Sage Dow practices at 3300 Main St, Springfield, MA 011071112. Office phone: 4137947552.
What is Dr. Sage Dow's NPI?
Dr. Sage Dow's National Provider Identifier (NPI) is 1871009886, issued by NPPES.
Does Dr. Sage Dow accept Medicare assignment?
Dr. Sage Dow does not accept Medicare assignment for all services. Patients may be billed amounts beyond Medicare-allowed charges.
What procedures does Dr. Sage Dow commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.